lomvastomigmelanomaesophageal squamous cell carcinomaNSCLCESCCSCLCnon-small-cell lung cancer
…Background This first-in-human clinical study explored lomvastomig, an immunoglobulin G1-based Fc-silenced bispecific antibody tha…
1articles mentioning drugs
6drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: lomvastomig ×
lomvastomig
This drug is selected. Its supporting articles are shown below.